Navigation Links
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
Date:5/2/2013

/span> for the treatment of DFU, following its approval by Health Canada as a class IV medical device for the treatment of DFU in September 2012.

VPRIV - for the treatment of Gaucher disease (Type 1)

  • On March 21, 2013 the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion regarding an update to the clinical efficacy and safety section of the VPRIV Summary of Product Characteristics to include information on long term clinical data relating to efficacy and safety in skeletal pathology from the TKT025 extension study in Type 1 Gaucher patients.

Pipeline


Lisdexamfetamine dimesylate(1) ("LDX") - for the treatment of negative symptoms of schizophrenia ("NSS")

  • Shire has cancelled the NSS Phase 3 program after a review and prioritization of Shire's development portfolio and taking into account investment requirements for recent acquisitions. No patients had been dosed in the studies and this decision was not due to any safety issues with LDX in any patient population. Shire remains committed to continuing Phase 3 trials for MDD and BED and these are enrolling as expected.

(1) Currently marketed as VYVANSE in the US and ELVANSE® in certain territories in the EU for the treatment of ADHD.

HGT4510 - for Duchenne Muscular Dystrophy ("DMD")

  • In April 2013, following analysis of the results of toxicology studies, Shire discontinued development of HGT4510 and returned Shire's rights in the asset to Acceleron Pharma Inc. The development of HGT4510 was placed on clinical hold in February 2011, subject to the completion of the toxicology studies.

VASCUGEL® - for the treatment of end-stage renal disease.


    SOURCE Shire plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

    Related medicine technology :

    1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
    2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
    3. Nephros Appoints John C. Houghton as President and Chief Executive Officer
    4. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
    5. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
    6. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
    7. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
    8. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
    9. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
    10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
    11. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today announced validation by ... Authorization Application (MAA) for sebelipase alfa for LAL ... for accelerated assessment, which has the potential to ... The MAA, and the Biologics License Application ...
    (Date:12/24/2014)...  Lockton Dunning Benefits, the Dallas ... addition of Vice President Kim Foerster ... Consulting team, Excelsior Solutions. Foerster ... the position.  Most recently, she worked as the ... Pharmacy, where she has held various managerial positions ...
    (Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
    Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3Kim Foerster Joins Lockton Companies 2TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
    ... (NYSE: CVS ) today announced it has ... D business of Universal American (NYSE: UAM ... leading Medicare Prescription Drug Plan (PDP) sponsor based in Rye ... the size of CVS Caremark,s Medicare Part D program. ...
    ... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) ... 6 lots of Acetadote® (acetylcysteine) Injection, the Company,s injectable ... of a potentially toxic quantity of acetaminophen. Cumberland informed ... plans to voluntarily recall these lots of Acetadote as ...
    Cached Medicine Technology:CVS CAREMARK to Purchase Universal American's Medicare Part D Business 2CVS CAREMARK to Purchase Universal American's Medicare Part D Business 3CVS CAREMARK to Purchase Universal American's Medicare Part D Business 4Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 2Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 3
    (Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... and Market Analysis to 2023” focuses on the ... commercial opportunities in the colorectal cancer market. Stivarga ... treatment of colon or rectal cancer. Boehringer Ingelheim ... inhibitor, for the treatment of refractory CRC in ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company ... collection of discounted prom dresses, most of which are ... of the company, the promotion is valid until Jan. ... expand the UK market. , The prom dresses in ... and styles: A-line strapless, empire strapless chiffon, one shoulder, ...
    (Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
    (Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
    (Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
    Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
    ... for her track record and accomplishments in customer and ... the promotion of Robin Hand to Vice President of ... has an excellent track record in managing customer inquiries, ... exceed every customer request. Through her leadership, she has ...
    ... EDI Health Group, Inc. (EHG), a,provider of ... payers and providers in the dental industry, today,announced ... QSII ) to serve as a,clearinghouse and ... and its providers and payers. , ...
    ... Women,s Health Marks 64 Years of Innovation and ... Pharmacal Company this year celebrates 64 years of ... for women,s health. For more than six ... consumers, lives through innovative, science-based, quality pharmaceutical products, ...
    ... TMK ) will release Fourth Quarter 2008 earnings ... In conjunction with Torchmark,s Fourth Quarter 2008 Earnings Release, you ... be broadcast live over the Internet on Thursday, February 5, ... copy of the Company,s Q4-2008 earnings press release and any ...
    ... Loss, Proper Nutrition, and Fitness now no longer just a New ... a Nation at www.MaxMuscle.com/max-formation/ . , ... Anaheim, ... most anticipated releases ever from Max Muscle Sports Nutrition , ...
    ... Sciences Organization Attracted to Florida to Open its Doors, with Ceremonies ... ... (Vocus) February 2, 2009 -- More than 200 community, government and ... Institute for Molecular Studies, (TPIMS) headquarters in the Florida Center ...
    Cached Medicine News:Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 2Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 3Health News:Mission Pharmacal Celebrates Historic Milestone 2Health News:Torchmark Corporation Announces Fourth Quarter 2008 Earnings Release and Conference Call 2Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 2Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 3Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 4Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 2Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 3
    ... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
    ... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
    ... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
    ... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
    Medicine Products: